See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Millions of Americans with obesity could soon gain access to popular ...

Over 38 million Americans have diabetes, according to the Centers for Disease Control and Prevention (CDC), and more than 90% of these cases are Type 2 diabetes. Managing Type 2 diabetes requires you ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded coverage of costly anti-obesity drugs to more than 7 million Americans on ...

Medicare prescription drug plans generally cover semaglutide in pill form. These plans include Part D and Medicare Advantage plans with drug benefits. Semaglutide is a type of drug called a ...